Sonendo

Sonendo, Inc. is a medical technology company that has developed and is commercializing the GentleWave System to treat tooth decay. It offers practice management software to enable an integrated digital office for dental practitioners. The company was founded by Olav B. Bergheim in 2006 and is headquartered in Laguna Hills, CA.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Sonendo reports robust Q4 earnings, eyes GP market expansion

Sonendo's Q4 2022 performance reflects strong revenue growth, milestone achievements, and strategic initiatives aimed at driving profitability and market expansion.
The company's focus on innovation, pricing strategies, and market diversification positions it well for sustained growth and competitive advantage in the dental technology sector.
While facing challenges in adoption transitions and market expansion, Sonendo has opportunities to capitalize on product innovation, market expansion, and strategic investments for future success.
Overall, Sonendo's performance, strengths, challenges, and opportunities indicate a positive outlook for continued growth, profitability, and market leadership in the dental technology industry.

Sonendo reports robust Q1 performance, eyes growth in GP market

Sonendo's Q1 2023 performance showed strong revenue growth and improved gross margins.
The company is capitalizing on the market interest in GentleWave consoles, especially the new G4 systems.
Challenges include longer sales cycles and the need to adapt to changing customer mindsets.
Opportunities lie in expanding market reach among general practitioners and enhancing operational efficiencies.

Sonendo reports $11M revenue in Q2 2023, focuses on margin improvement

Sonendo's Q2 2023 performance showed revenue growth driven by PI sales but offset by declining console revenue, with a focus on margin improvement and expense management.
Strengths include strong PI sales growth, initiatives to enhance margins, and strategic efforts to educate GPs about the GentleWave procedure.
Challenges include declining console placements, expense management actions, and revised revenue guidance due to sales cycle elongation.
Opportunities lie in leveraging PI sales growth, educating GPs, improving margins, and adapting to market dynamics for future growth and profitability.

Sonendo reports revenue growth amidst challenges, eyes market expansion

Sonendo's Q3 performance showed revenue growth but with high operating expenses.
The company is focusing on revenue growth, margin improvement, and cash preservation.
Challenges include declining consumable sales and ongoing debt covenant discussions.
Opportunities lie in market expansion, margin enhancement, and cost reduction efforts.

Sonendo reports mixed Q4 results, sets ambitious targets for 2024

Sonendo's 2023 performance showed revenue growth and margin improvement, with strategic divestments and debt restructuring enhancing financial flexibility.
While facing challenges in specific product sales and cost management, the company aims to capitalize on growth opportunities in 2024.
Clear communication on guidance, margins, and strategies can position Sonendo for sustainable growth and profitability in the coming year.

Sonendo exceeds Q1 revenue target, focuses on margin expansion

Sonendo's Q1 2024 earnings call highlighted a solid performance, operational strengths, challenges in revenue diversification, and opportunities for growth.
The company's focus on cost-saving measures, margin expansion, and strategic initiatives positions them well for future success and market competitiveness.
Investors should monitor Sonendo's execution of their strategic plan and revenue diversification efforts to assess long-term sustainability and growth potential.

Sonendo reports strong Q2 performance, raises revenue guidance

Sonendo's Q2 2024 performance reflects positive momentum and strategic alignment with growth objectives.
The company's focus on innovation, cost optimization, and revenue growth positions it well for future success.
While challenges exist, Sonendo's proactive approach and market opportunities bode well for sustained performance.
Overall, Sonendo's financial health and operational improvements signal a promising outlook for investors.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Sonendo, Inc. is a medical technology company, which developed and manufactures the GentleWave System to treat tooth decay. It operates through the Product and Software segments. The Product segment includes the sales of the GentleWave System console and related accessories and instruments. The Software segment focuses on the sales of traditional software licenses for practice management software to enable an integrated digital office for endodontists. The company was founded by Olav B. Bergheim in June 2006 and is headquartered in Laguna Hills, CA.

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® Procedure, a less invasive alternative to traditional root canal therapy, today announced the results of its recent survey, which revealed widespread anxiety and fear surrounding traditional root canal treatment without the use of the GentleWave Procedure. The national survey gathered responses from consumers ages 35 and older, with 60% of respondents having pr

New Survey Reveals 77% of Americans Would Rather Sleep at the Airport Than Have Root Canal Treatment

Kiromic Biopharma

NanoVibronix

Use this guide for investing in penny stocks in the long term The post Long Term Penny Stocks Investing Strategy (Complete Guide) appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Long Term Penny Stocks Investing Strategy (Complete Guide)

Source: NicoElNino / Shutterstock.com Sonendo (NYSE: SONX ) is rising higher on Friday as investors react to a $63 million private placement of its common stock. According to a press release, several returning and new investors took part in the private placement.

Why Is Sonendo (SONX) Stock Up 15% Today?

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced a private placement of common stock and pre-funded warrants, resulting in gross proceeds of $63 million. New and existing investors, including Pura Vida Investments, First Light Asset Management, Blue Water Life Science Advisors, ArrowMark Partners, Driehaus Capital Management, and JMR Capital participated in the financing. “We are excit

Sonendo, Inc. Announces $63 Million Private Placement

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced it will be sponsoring the first-ever Women in Endodontics summit. Taking place in Tucson, Ariz. at the Miraval Resort from Sept. 23-25, the two-day experience will offer educational sessions led by nationally recognized endodontists and instructors, as well as activities designed to promote networking, connection and well-being with a fo

Sonendo® Sponsors Inaugural Women in Endodontics Summit

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that management will be participating in the upcoming Morgan Stanley 20th Annual Global Healthcare Conference. Management is scheduled to present on Tuesday, September 13 at 2:55 p.m. Eastern Time. An audio webcast of the presentation will be available on the “Investors” section of the company's website at: investor.sonendo.com. About So

Sonendo, Inc. to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

Sonendo, Inc. (NYSE:SONX ) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants Matt Bacso - Gilmartin Group Bjarne Bergheim - President and Chief Executive Officer Michael Watts - Chief Financial Officer Conference Call Participants Michael Cherny - Bank of America Jonathan Block - Stifel Jason Bednar - Piper Sandler Nathan Rich - Goldman Sachs Erin Wright - Morgan Stanley Operator Good afternoon and welcome to Sonendo's Second Quarter Earnings Conference Call. At this time, all participants are in listen-only mode.

Sonendo, Inc. (SONX) CEO Bjarne Bergheim on Q2 2022 Results - Earnings Call Transcript

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (“Sonendo”), a leading dental technology company and developer of the GentleWave® System, today reported financial results for the quarter ended June 30, 2022. Recent Highlights Total revenue of $10.5 million for the second quarter of 2022, representing growth of 32%, compared to prior year period GentleWave's ending install base as of June 30, 2022, was approximately 900 units Announced full commercial launch of CleanFlow® Technology on Apri

Sonendo, Inc. Reports Second Quarter 2022 Financial Results

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (“Sonendo”) (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that it will report financial results for the second quarter 2022 after the market close on Wednesday, August 10, 2022. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results. Investors interested in listening to the conference call may do so by dia

Sonendo, Inc. to Report Second Quarter 2022 Financial Results on August 10, 2022

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced the appointment of Joanne Lindberg as Vice President of Sales, North America. As Sonendo continues to scale and further establish its leadership position within the endodontic market, Lindberg will oversee sales strategy and execution across the United States and Canada. With a focus on increasing adoption and driving utilization of the

Sonendo, Inc. Welcomes Joanne Lindberg as Vice President of Sales, North America

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced two upcoming departures from its executive management team. Jacqueline Collins, vice president, general counsel, and Merhzad Khakpour, chief technology officer, will each leave the company in July for other opportunities. In 2018 Ms. Collins became Sonendo's first general counsel, bringing extensive expertise in medical device and intell

Sonendo, Inc. Announces Executive Management Team Changes

Award-winning PR and marketing firm to raise brand awareness for leading dental technology company through a multi-channel communications and media relations program SAN DIEGO, May 24, 2022 /PRNewswire/ -- Crowe PR, a national public relations and marketing agency, today announced leading dental technology company Sonendo, Inc. (NYSE: SONX) has named the award-winning firm its agency of record. Crowe PR's integrated healthcare and technology teams will handle strategic communications, messaging refinement, media relations and thought leadership on behalf of Sonendo, raising awareness for the brand, its GentleWave® System and executive team.

Sonendo, Inc. Names Crowe PR as Agency of Record

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that management will be participating in the upcoming Stifel Jaws and Paws Conference. Bjarne Bergheim, President & Chief Executive Officer, and Michael Watts, Chief Financial Officer, are scheduled to present on Wednesday, June 1 at 8:35 a.m. Eastern Time. An audio webcast of the presentation will be available on the “Investors” sec

Sonendo, Inc. to Present at the Stifel Jaws and Paws Conference

Sonendo, Inc. (NYSE:SONX ) Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Bjarne Bergheim – President and Chief Executive Officer Michael Watts – Chief Financial Officer Matt Bacso – Managing Director of Gilmartin Group Conference Call Participants Jason Bednar – Piper Sandler Nathan Rich – Goldman Sachs Group Erin Wright – Morgan Stanley Operator Good afternoon and welcome to the Sonendo, Inc. Q1 2022, Earnings Conference Call. My name is Brika (ph), and I'll be today's event specialist.

Sonendo, Inc. (SONX) CEO Bjarne Bergheim on Q1 2022 Results - Earnings Call Transcript

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (“Sonendo”), a leading dental technology company and developer of the GentleWave® System, today reported financial results for the quarter ended March 31, 2022. Recent Highlights Total revenue of $9.0 million for the first quarter of 2022, representing growth of 22%, compared to prior year period Announced full commercial launch of CleanFlow® Technology on April 20, 2022 Amended credit agreement with Perceptive Credit Holdings, providing an a

Sonendo, Inc. Reports First Quarter 2022 Financial Results

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, is participating in the American Association of Endodontists' (AAE) Annual Meeting taking place from April 27-30, 2022 in Phoenix, AZ. The highly anticipated AAE annual meeting is the world's most comprehensive endodontic education summit, vendor exhibition and networking opportunity. This marks the first in-person annual meeting of the AAE since 2019,

Sonendo, Inc. To Showcase Newly Launched CleanFlow™ Technology at 2022 AAE Annual Meeting

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced the launch of its CleanFlow™ procedure instrument, which is designed to work with Sonendo's GentleWave System to provide a less invasive and less painful alternative to traditional root canal therapy. With the addition of CleanFlow Technology, the GentleWave procedure now enables a simpler workflow as compared to earlier GentleWave proce

Sonendo Announces Launch of CleanFlow™ Technology to Improve Doctor and Patient Experience

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (“Sonendo”) (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that it will report financial results for the first quarter 2022 after the market close on Tuesday, May 10, 2022. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results. Investors interested in listening to the conference call may do so by dialing (

Sonendo, Inc. to Report First Quarter 2022 Financial Results on May 10, 2022, and Attend the 2022 Bank of America Healthcare Conference on May 11, 2022

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced the launch of its GentleWave Community app, an industry-first app in endodontics designed specifically for users of the GentleWave System. The GentleWave Community app provides doctors who use the GentleWave System with a private, peer-to-peer forum to share and seek treatment insights and tips from fellow GentleWave providers. Topics in

Sonendo, Inc. Launches GentleWave Community App, an Exclusive Forum for GentleWave Providers to Share Clinical and Practice Insights and Resources

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that management will be participating in the upcoming Piper Sandler Dental Day. Bjarne Bergheim, President & Chief Executive Officer, and Michael Watts, Chief Financial Officer, are scheduled to present on Tuesday, March 29 at 12:00 p.m. Eastern Time. An audio webcast of the presentation will be available on the “Investors” section o

Sonendo, Inc. to Present at Piper Sandler & Co. Dental Day

Sonendo, Inc. (SONX) CEO Bjarne Bergheim on Q4 2021 Results - Earnings Call Transcript

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (“Sonendo”), a leading dental technology company and developer of the GentleWave® System, today reported financial results for the quarter and year ended December 31, 2021. Recent Highlights Total revenue of $9.9 million for the fourth quarter of 2021, representing growth of 14%, compared to prior year period Total revenue of $33.2 million for full year 2021, representing growth of 42% from full year 2020 Ending 2021 with 24 Capital Sales Rep

Sonendo Inc. Reports Fourth Quarter 2021 Financial Results and Issues Full Year 2022 Revenue Guidance

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (NYSE: SONX), a dental technology company and creator of the GentleWave System for less invasive and less painful root canal therapy, today announced its achievement of a new milestone of 800,000 GentleWave patient procedures. The achievement of this newest milestone demonstrates the confidence doctors and their patients have in the GentleWave System as an alternative to traditional root canal therapy, and the growing utilization and preferen

Sonendo, Inc. Hits New Milestone of 800,000 GentleWave® Procedures, Demonstrating Continued Adoption and Growing Preference for Less Invasive Alternative to Traditional Root Canal Therapy

ironSource Ltd

Alignment Healthcare

Codiak Biosciences

Lyell Immunopharma

While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.

Goldman Sachs Has 5 Buy-Rated Stocks Under $10 With 100% to 700% Upside Potential

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (“Sonendo”) (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, today announced that it will report financial results for the fourth quarter and full year 2021 after the market close on Wednesday, March 23, 2022. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results. Investors interested in listening to the conference call may

News for Sonendo Stock (SONX)